Basit öğe kaydını göster

dc.contributor.authorKaan, Dilek
dc.contributor.authorToprak, Güler
dc.contributor.authorYay, Arzu
dc.contributor.authorBaşkol, Gülden
dc.contributor.authorErtekin, Tolga
dc.contributor.authorÜlger, Harun
dc.date.accessioned2022-09-26T08:29:54Z
dc.date.available2022-09-26T08:29:54Z
dc.date.issued2021en_US
dc.identifier.urihttps://dergipark.org.tr/tr/pub/medalanya/issue/61925/775667
dc.identifier.urihttps://hdl.handle.net/20.500.12868/1688
dc.description.abstractAim: In this study, it was aimed to reveal a more effective model depending on the dose and time by evaluating histopathological properties and biochemical parameters, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, triglyceride, cholesterol in carbon tetrachloride and thioacetamide (CCl4 and TAA) models. Method: Rats were divided into three groups for each model and intraperitoneally (i.p.) injected with CCl4 (0.5 ml/kg, 1.0 ml/kg, 2.0 ml/kg) and TAA (100 mg/kg, 200 mg/ kg, 300 mg/kg) for 4, 6 and 8 weeks, three times weekly, respectively. Results: In the biochemical investigation, ALT and AST values in the only 0,5 ml CCL4 of groups for 6 and 8 weeks and were found to have significant differences compared to the control groups (p <0.05), while the other biochemicals parameters values did not reveal significant difference in the groups (p >0.05). According to the results of the histopathology in the liver tissues, both the control groups showed a normal histological feature. The hepatofibrotic alterations were remarkable in the CCl4 and TAA models fibrosis depending on the increasing dose and time in all of the groups. Conclusion: Our results showed that the dose and time were reached up to until the cirrhosis for eighth week. These results would be a helpful reference for hepatofibrotic studies.en_US
dc.language.isoengen_US
dc.relation.isversionofhttps://doi.org/10.30565/medalanya.775667en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectTAAen_US
dc.subjectCCIen_US
dc.subjectLiveren_US
dc.subjectFibrosisen_US
dc.titleDetermination of effects of chemical agencies on liver fibrosis models frequently used in different dose and time periotsen_US
dc.typearticleen_US
dc.contributor.departmentALKÜen_US
dc.identifier.volume5en_US
dc.identifier.issue1en_US
dc.identifier.startpage4en_US
dc.identifier.endpage10en_US
dc.relation.journalActa Medica Alanyaen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Başka Kurum Yazarıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster